Hub : Traits

Reaction time omissions

Number of times that the rat failed to make a response within 3 sec of the onset of the imperative stimulus in the last three 18-minute sessions for males and females [n]

Tags: Behavior · Reaction time

Project: p50_david_dietz

4 loci · 4 genes with independent associations · 6 total associated genes

Significant Loci

#	Chr	Start pos	End pos	# assoc genes	# joint models	Best TWAS P	Best GWAS P	Cond GWAS P	Joint genes
1	chr2	124066339	125075599	3	1	3.09e-08	2.57e-07	8.26e-113	C2h4orf33
2	chr8	108585012	109845634	1	1	1.23e-08	4.07e-01	2.36e-03	Klhdc8b
3	chr9	75969545	77365260	1	1	1.53e-15	7.61e-01	1.00e+00	Zfand2b
4	chr14	34177603	35456143	1	1	2.65e-09	3.56e-02	1.00e+00	Ociad2

Pleiotropic Associations

Trait	Chi2 ratio	# genes+	# genes++	% genes++	Corr	Corr P	Genes
BMI with tail	8.54	4	3	75	-0.47	3.52e-01	C2h4orf33 Klhdc8b Ociad2 Zfand2b
BMI without tail	28.48	3	2	50	0	1.00e+00	Klhdc8b Ociad2 Zfand2b
Body weight	7.17	3	1	25	-0.7	1.86e-01	C2h4orf33 Klhdc8b Ociad2
Epididymis fat weight	111.28	1	1	25	0	1.00e+00	Zfand2b
Heart weight	32.96	3	1	25	0	1.00e+00	Klhdc8b Ociad2 Zfand2b
Left kidney weight	27.82	3	3	75	0	1.00e+00	Klhdc8b Ociad2 Zfand2b
Right kidney weight	23.53	3	2	50	0	1.00e+00	Klhdc8b Ociad2 Zfand2b
Tail length	66.87	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Length with tail	5.48	3	1	25	0	1.00e+00	Klhdc8b Ociad2 Zfand2b
Length without tail	77.43	1	1	25	0	1.00e+00	Zfand2b
Liver weight, left	13.45	1	0	0	0	1.00e+00	Klhdc8b
Liver weight, right	17.57	1	1	25	0	1.00e+00	Zfand2b
Parametrial fat weight	9.99	1	0	0	0	1.00e+00	Zfand2b
Retroperitoneal fat weight	6.88	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Intraocular pressure	51.69	1	1	25	0	1.00e+00	Zfand2b
Extensor digitorum longus weight	1.79	1	0	0	0	1.00e+00	Ociad2
Soleus weight	8.84	1	0	0	0	1.00e+00	Klhdc8b
Tibia length	9.14	2	1	25	0	1.00e+00	Klhdc8b Ociad2
Number of licking bursts	28.51	2	2	50	0	1.00e+00	Klhdc8b Zfand2b
Food consumed during 24 hour testing period	12.4	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Times rat made contact with spout	9.25	1	0	0	0	1.00e+00	Zfand2b
Mean time between licks in bursts	7.18	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Mean num. licks in bursts	14.92	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Std. dev. time between licks in bursts	12.12	1	0	0	0	1.00e+00	Zfand2b
Water consumed over 24 hours	21.34	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Patch foraging indifference point 0 sec	9.99	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Patch foraging indifference point AUC	24.2	1	1	25	0	1.00e+00	Zfand2b
Indifference point function ln k	35.82	3	2	50	0	1.00e+00	Klhdc8b Ociad2 Zfand2b
Indifference point function log k	35.82	3	2	50	0	1.00e+00	Klhdc8b Ociad2 Zfand2b
Patch foraging total patch changes 0 sec	16.18	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Patch foraging total patch changes 18 sec	30.97	2	1	25	0	1.00e+00	Ociad2 Zfand2b
Patch foraging total patch changes 24 sec	32.78	3	1	25	0	1.00e+00	Klhdc8b Ociad2 Zfand2b
Patch foraging total patch changes 6 sec	24.67	1	1	25	0	1.00e+00	Zfand2b
Patch foraging time to switch 0 sec	15.51	3	1	25	0	1.00e+00	Klhdc8b Ociad2 Zfand2b
Patch foraging water rate 0 sec	39.47	1	1	25	0	1.00e+00	Zfand2b
Patch foraging water rate 12 sec	69.49	1	1	25	0	1.00e+00	Zfand2b
Patch foraging water rate 18 sec	9.71	1	0	0	0	1.00e+00	Zfand2b
Patch foraging water rate 24 sec	12.61	1	0	0	0	1.00e+00	Zfand2b
Patch foraging water rate 6 sec	20.41	2	1	25	0	1.00e+00	Ociad2 Zfand2b
Locomotor activity	35.08	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Locomotor testing distance	55.86	2	2	50	0	1.00e+00	Klhdc8b Zfand2b
Locomotor testing rearing	99.51	1	1	25	0	1.00e+00	Zfand2b
Light reinforcement 1	19.25	1	1	25	0	1.00e+00	Zfand2b
Light reinforcement 2	6.84	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Reaction time number correct	66.72	2	2	50	0	1.00e+00	Klhdc8b Zfand2b
Reaction time mean minus median	53.94	2	1	25	1	2.77e-04	C2h4orf33 Zfand2b
Reaction time mean minus median AUC	64.33	2	1	25	1	4.56e-04	C2h4orf33 Zfand2b
Reaction time num false alarms	9.55	3	0	0	0	1.00e+00	Klhdc8b Ociad2 Zfand2b
Reaction time num false alarms AUC	14.65	3	1	25	0	1.00e+00	Klhdc8b Ociad2 Zfand2b
Reaction time trials correct on left	66.72	2	2	50	0	1.00e+00	Klhdc8b Zfand2b
Reaction time trials on left	63.1	2	2	50	0	1.00e+00	Klhdc8b Zfand2b
Reaction time mean	15.5	3	1	25	0.77	1.27e-01	C2h4orf33 Ociad2 Zfand2b
Reaction time mean AUC	14.84	4	1	25	0.77	7.42e-02	C2h4orf33 Klhdc8b Ociad2 Zfand2b
Median of all reaction times	9.58	4	0	0	0.72	1.05e-01	C2h4orf33 Klhdc8b Ociad2 Zfand2b
Reaction time false alarm rate	14.87	2	1	25	0	1.00e+00	Klhdc8b Ociad2
Reaction time premature initiations	14.63	3	1	25	-0.84	1.59e-01	C2h4orf33 Klhdc8b Zfand2b
Std. dev. reaction times	29.3	2	1	25	1	4.05e-04	C2h4orf33 Zfand2b
Reaction time trials completed	63.1	2	2	50	0	1.00e+00	Klhdc8b Zfand2b
Reaction time trials AUC	64.7	2	2	50	0	1.00e+00	Klhdc8b Zfand2b
Conditioned locomotion	17.57	2	1	25	0	1.00e+00	Klhdc8b Ociad2
Cocaine response after cond. corrected	12.71	1	0	0	0	1.00e+00	Zfand2b
Cocaine response after cond. not corrected	13.66	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Cocaine response before conditioning	38.66	1	1	25	0	1.00e+00	Klhdc8b
Saline control response	8.61	2	0	0	0	1.00e+00	Ociad2 Zfand2b
Condit. Reinf. active minus inactive responses	8.59	2	0	0	0	1.00e+00	C2h4orf33 Ociad2
Condit. Reinf. active-inactive response ratio	11.1	2	0	0	-0.9	1.03e-01	C2h4orf33 Ociad2
Condit. Reinf. active responses	18.34	1	0	0	0	1.00e+00	Ociad2
Condit. Reinf. inactive responses	10.2	1	0	0	0	1.00e+00	Ociad2
Condit. Reinf. lever presses	5.61	2	0	0	0	1.00e+00	Ociad2 Zfand2b
Condit. Reinf. lever reinforcers received	12.87	1	0	0	0	1.00e+00	Ociad2
Pavlov. Cond. magazine entry number	30	1	1	25	0	1.00e+00	Klhdc8b
Pavlov. Cond. intertrial magazine entries	7.56	1	0	0	0	1.00e+00	Klhdc8b
Pavlov. Cond. response bias	5.18	1	0	0	0	1.00e+00	Klhdc8b
Conditioned reinforcement - actives	152.54	1	1	25	0	1.00e+00	Zfand2b
Conditioned reinforcement - inactives	76.2	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Conditioned locomotion	13.93	1	0	0	0	1.00e+00	Zfand2b
Intermittent access intake day 1-15 change	156.77	1	1	25	0	1.00e+00	Zfand2b
Intermittent access intake escalation	117.41	1	1	25	0	1.00e+00	Zfand2b
Intermitt. access day 1 inactive lever presses	91.66	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Intermitt. access day 15 inactive lever presses	162.52	2	2	50	0	1.00e+00	Klhdc8b Zfand2b
Intermitt. access escalation Index	38.02	1	1	25	0	1.00e+00	Ociad2
Intermittent access day 1 total infusions	39.22	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Intermittent access day 15 total infusions	24.8	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Intermittent access terminal intake (last 3 days)	24.92	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Intermittent access total infusions	15.45	1	0	0	0	1.00e+00	Klhdc8b
Intermittent access day 1 locomotion	18.98	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Intermittent access day 15 total locomotion	93.08	1	1	25	0	1.00e+00	Zfand2b
Intermittent access total locomotion	12.43	1	0	0	0	1.00e+00	Zfand2b
Intermittent access standard deviation	229.66	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Cocaine induced anxiety	69.5	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Post-drug Anxiety	21.14	1	0	0	0	1.00e+00	Ociad2
Baseline Anxiety	393.92	1	1	25	0	1.00e+00	Zfand2b
Lifetime Intake	9.49	1	0	0	0	1.00e+00	Klhdc8b
Incentive Sensitization - Responses	309.83	1	1	25	0	1.00e+00	Zfand2b
Incentive Sensitization - Breakpoint	300.45	1	1	25	0	1.00e+00	Zfand2b
Progressive ratio test 1 active lever presses	26.41	1	1	25	0	1.00e+00	Zfand2b
Progressive ratio test 1 breakpoint	19.19	1	0	0	0	1.00e+00	Zfand2b
Progressive ratio test 1 inactive lever presses	12.85	2	0	0	0	1.00e+00	Klhdc8b Ociad2
Progressive ratio test 2 active lever presses	109.22	1	1	25	0	1.00e+00	Zfand2b
Progressive ratio test 2 breakpoint	106.65	1	1	25	0	1.00e+00	Zfand2b
Progressive ratio test 2 inactive lever presses	37.15	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Total sessions with >9 infusions	16	1	0	0	0	1.00e+00	Klhdc8b
Short access day 1 total inactive lever presses	17.49	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Short access day 10 total inactive lever presses	72.35	2	2	50	0	1.00e+00	Klhdc8b Zfand2b
Short access day 10 total infusions	13.17	1	0	0	0	1.00e+00	Klhdc8b
Short access day 1 locomotion	70.49	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Short access day 10 total locomotion	432.47	1	1	25	0	1.00e+00	Zfand2b
Short access total locomotion	209.96	1	1	25	0	1.00e+00	Zfand2b
Compulsive drug intake	68.39	1	1	25	0	1.00e+00	Zfand2b
One hour access (0.3 mA shock)	18.01	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
One hour access (shock baseline)	8.36	1	0	0	0	1.00e+00	Klhdc8b
Number of responses in last shaping day	67.75	1	1	25	0	1.00e+00	Zfand2b
Locomotion distance, session 1	23.98	1	1	25	0	1.00e+00	Klhdc8b
Locomotion velocity, session 2	10	1	0	0	0	1.00e+00	Klhdc8b
Locomotion distance, session 2	33.15	1	1	25	0	1.00e+00	Klhdc8b
Locomotion velocity, session 3	17.14	1	0	0	0	1.00e+00	Klhdc8b
Locomotion distance, session 3	14.51	1	0	0	0	1.00e+00	Klhdc8b
Stereotopy head waving duration, day 3	6.96	1	0	0	0	1.00e+00	Klhdc8b
Locomotion velocity, session 8	9.36	1	0	0	0	1.00e+00	Klhdc8b
Locomotion distance, session 8	52.78	1	1	25	0	1.00e+00	Klhdc8b
Degree of sensitization distance	24.75	1	0	0	0	1.00e+00	Klhdc8b
Condit. Reinf. active minus inactive responses	35.59	1	1	25	0	1.00e+00	Klhdc8b
Condit. Reinf. active-inactive response ratio	25.6	1	1	25	0	1.00e+00	Klhdc8b
Condit. Reinf. active responses	18.23	1	0	0	0	1.00e+00	Klhdc8b
Incentive salience index mean	26.23	1	1	25	0	1.00e+00	Klhdc8b
Condit. Reinf. lever presses	10.81	1	0	0	0	1.00e+00	Klhdc8b
Time in familiar zone, hab. session 1	63.49	1	1	25	0	1.00e+00	Klhdc8b
Time in novel zone, hab. session 1	13.1	1	0	0	0	1.00e+00	Klhdc8b
Total zone transitions, hab. session 1	37.38	1	1	25	0	1.00e+00	Klhdc8b
Total locomotion distance, hab. session 1	10.76	1	0	0	0	1.00e+00	Klhdc8b
Locomotion velocity, hab. session 1	10.22	1	0	0	0	1.00e+00	Klhdc8b
Time in familiar zone, hab. session 2	27.1	1	1	25	0	1.00e+00	Klhdc8b
Time in novel zone, hab. session 2	8.89	2	0	0	0	1.00e+00	C2h4orf33 Klhdc8b
Total zone transitions, hab. session 2	69.58	1	1	25	0	1.00e+00	Klhdc8b
Total locomotion distance, hab. session 2	19.2	1	0	0	0	1.00e+00	Klhdc8b
Locomotion velocity, hab. session 2	21.15	1	1	25	0	1.00e+00	Klhdc8b
Novel to familiar place preference ratio	22.33	1	0	0	0	1.00e+00	Klhdc8b
Novelty place preference	20.99	1	0	0	0	1.00e+00	Klhdc8b
Time in novel zone, NPP test	17.06	1	0	0	0	1.00e+00	Klhdc8b
Total zone transitions, NPP test	106.24	1	1	25	0	1.00e+00	Klhdc8b
Total locomotion distance, NPP test	47.64	1	1	25	0	1.00e+00	Klhdc8b
Locomotion velocity, NPP test	51.12	1	1	25	0	1.00e+00	Klhdc8b
Pavlov. Cond. magazine entry latency	6.8	1	0	0	0	1.00e+00	Ociad2
Pavlov. Cond. change in total contacts	69.48	1	1	25	0	1.00e+00	Klhdc8b
Pavlov. Cond. index score	14.07	1	0	0	0	1.00e+00	Klhdc8b
Pavlov. Cond. latency score	8.82	1	0	0	0	1.00e+00	Klhdc8b
Pavlov. Cond. magazine entry number	10.3	2	0	0	0	1.00e+00	Klhdc8b Ociad2
Pavlov. Cond. intertrial magazine entries	6.49	1	0	0	0	1.00e+00	Ociad2
Pavlov. Cond. lever-magazine prob. diff.	14.82	1	0	0	0	1.00e+00	Klhdc8b
Pavlov. Cond. response bias	10.49	1	0	0	0	1.00e+00	Klhdc8b
Bone: apparent density	6.77	1	0	0	0	1.00e+00	Ociad2
Bone: cortical thickness	10.85	1	0	0	0	1.00e+00	Ociad2
Bone: endosteal estimation	3.9	2	0	0	0	1.00e+00	Klhdc8b Ociad2
Bone: final force	6.04	2	0	0	0	1.00e+00	Klhdc8b Ociad2
Bone: final moment	4.73	1	0	0	0	1.00e+00	Ociad2
Bone: marrow area	3.54	1	0	0	0	1.00e+00	Ociad2
Bone: maximum force	7.53	2	0	0	0	1.00e+00	Klhdc8b Ociad2
Bone: maximum moment	4.96	1	0	0	0	1.00e+00	Ociad2
Bone: minimum diameter	9.13	1	0	0	0	1.00e+00	Ociad2
Bone: post-yield work	6.07	1	0	0	0	1.00e+00	C2h4orf33
Bone: stiffness	9.19	2	0	0	0	1.00e+00	Klhdc8b Ociad2
Bone: trabecular number	5.07	1	0	0	0	1.00e+00	Ociad2
Distance traveled after self-admin	9.07	2	0	0	0	1.00e+00	Ociad2 Zfand2b
Delta time in closed arm before/after self-admin	12.84	1	0	0	0	1.00e+00	Klhdc8b
Delta time in open arm before/after self-admin	26.67	1	0	0	0	1.00e+00	Zfand2b
Active lever presses in extinction session 6	16.82	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Delta distance traveled before/after self-admin	8.93	1	0	0	0	1.00e+00	Ociad2
Delta ambulatory time before/after self-admin	6.6	1	0	0	0	1.00e+00	Ociad2
Time in closed arm before self-admin	44.32	1	1	25	0	1.00e+00	Zfand2b
Time in closed arm after self-admin	9.97	1	0	0	0	1.00e+00	Ociad2
Time in open arm before self-admin	24.67	1	0	0	0	1.00e+00	Zfand2b
Time to tail flick, vehicle, after self-admin	56.6	2	2	50	0	1.00e+00	Klhdc8b Zfand2b
Time to tail flick, test, before self-admin	8.99	2	0	0	0	1.00e+00	Ociad2 Zfand2b
Delta time to tail flick, vehicle, before/after SA	44.54	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Ambulatory time before self-admin	25.36	1	0	0	0	1.00e+00	Zfand2b
Total heroin consumption	13.42	2	0	0	0	1.00e+00	Klhdc8b Ociad2
Area under the delay curve	31.15	1	1	25	0	1.00e+00	Zfand2b
Delay disc. indifference point, 0s delay	28.7	1	1	25	0	1.00e+00	Klhdc8b
Delay disc. indifference point, 16s delay	41.08	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Delay disc. indifference point, 24s delay	27.43	1	0	0	0	1.00e+00	Zfand2b
Delay disc. indifference point, 4s delay	41.82	1	1	25	0	1.00e+00	Klhdc8b
Delay disc. indifference point, 8s delay	74.24	1	1	25	0	1.00e+00	Zfand2b
Delay discount exponential model param	16.14	1	0	0	0	1.00e+00	Zfand2b
Delay discount hyperbolic model param	15.89	1	0	0	0	1.00e+00	Zfand2b
Fecal boli incidents, locomotor time 1	96.73	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Time >=10cm from walls, locomotor time 1	43.35	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Rest time, locomotor task time 1	17.01	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Distance moved, locomotor task time 1	31.01	1	1	25	0	1.00e+00	Klhdc8b
Vertical activity count, locomotor time 1	73.36	2	2	50	0	1.00e+00	Klhdc8b Zfand2b
Bouts of movement, locomotor time 2	21.88	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Total resting periods, locomotor time 2	28.25	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Rest time, locomotor task time 2	35.13	2	2	50	0	1.00e+00	Klhdc8b Zfand2b
Distance moved, locomotor task time 2	63.13	2	2	50	0	1.00e+00	Klhdc8b Zfand2b
Vertical activity count, locomotor time 2	34.04	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Weight adjusted by age	20.12	2	1	25	0	1.00e+00	Klhdc8b Zfand2b
Seeking ratio, delayed vs. immediate footshock	8.74	1	0	0	0	1.00e+00	Zfand2b
Locomotion in novel chamber post-restriction	14.04	1	0	0	0	1.00e+00	Zfand2b
Progressive ratio	7.25	1	0	0	0	1.00e+00	Klhdc8b
Food seeking constrained by brief footshock	13.85	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Run reversals in cocaine runway, females	21.9	2	1	25	0	1.00e+00	Ociad2 Zfand2b
Run reversals in cocaine runway, males	10.49	1	0	0	0	1.00e+00	Ociad2
Latency to leave start box in cocaine runway	34.23	1	1	25	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway, F	31.9	1	1	25	0	1.00e+00	Zfand2b
Cd content in liver	14	2	0	0	0	1.00e+00	Klhdc8b Ociad2
Cu content in liver	5.79	1	0	0	0	1.00e+00	Ociad2
Fe content in liver	40.39	1	1	25	0	1.00e+00	Klhdc8b
K content in liver	12.22	1	0	0	0	1.00e+00	Klhdc8b
Mg content in liver	15.79	1	0	0	0	1.00e+00	Klhdc8b
Na content in liver	16.36	1	0	0	0	1.00e+00	Klhdc8b
Rb content in liver	28.8	2	1	25	0	1.00e+00	Klhdc8b Ociad2
Se content in liver	25.21	2	1	25	0	1.00e+00	Klhdc8b Ociad2
Sr content in liver	20.51	2	0	0	0	1.00e+00	Klhdc8b Ociad2
Zn content in liver	9.95	1	0	0	0	1.00e+00	Klhdc8b

Associations by panel

Tissue	RNA modality	# hits	% hits/tests	Avg chisq
Adipose	alternative polyA	0	0	1.3
Adipose	alternative TSS	0	0	1.33
Adipose	gene expression	0	0	1.33
Adipose	isoform ratio	0	0	1.28
Adipose	intron excision ratio	0	0	1.22
Adipose	mRNA stability	0	0	1.34
BLA	alternative polyA	0	0	1.48
BLA	alternative TSS	0	0	1.39
BLA	gene expression	0	0	1.35
BLA	isoform ratio	0	0	1.36
BLA	intron excision ratio	0	0	1.4
BLA	mRNA stability	0	0	1.38
Brain	alternative polyA	0	0	1.5
Brain	alternative TSS	0	0	1.44
Brain	gene expression	0	0	1.35
Brain	isoform ratio	0	0	1.43
Brain	intron excision ratio	1	0	1.4
Brain	mRNA stability	0	0	1.37
Eye	alternative polyA	0	0	1.61
Eye	alternative TSS	0	0	1.37
Eye	gene expression	0	0	1.4
Eye	isoform ratio	0	0	1.37
Eye	intron excision ratio	0	0	1.31
Eye	mRNA stability	0	0	1.35
IL	alternative polyA	0	0	1.42
IL	alternative TSS	0	0	1.33
IL	gene expression	0	0	1.37
IL	isoform ratio	0	0	1.37
IL	intron excision ratio	0	0	1.53
IL	mRNA stability	0	0	1.39
LHb	alternative polyA	0	0	1.4
LHb	alternative TSS	0	0	1.37
LHb	gene expression	0	0	1.33
LHb	isoform ratio	0	0	1.34
LHb	intron excision ratio	0	0	1.36
LHb	mRNA stability	0	0	1.31
Liver	alternative polyA	0	0	1.44
Liver	alternative TSS	0	0	1.24
Liver	gene expression	1	0	1.3
Liver	isoform ratio	0	0	1.31
Liver	intron excision ratio	0	0	1.28
Liver	mRNA stability	0	0	1.32
NAcc	alternative polyA	0	0	1.4
NAcc	alternative TSS	0	0	1.39
NAcc	gene expression	0	0	1.36
NAcc	isoform ratio	0	0	1.39
NAcc	intron excision ratio	0	0	1.36
NAcc	mRNA stability	0	0	1.35
OFC	alternative polyA	0	0	1.27
OFC	alternative TSS	0	0	1.51
OFC	gene expression	0	0	1.35
OFC	isoform ratio	0	0	1.46
OFC	intron excision ratio	0	0	1.44
OFC	mRNA stability	0	0	1.36
PL	alternative polyA	1	0	1.4
PL	alternative TSS	0	0	1.46
PL	gene expression	0	0	1.36
PL	isoform ratio	1	0	1.43
PL	intron excision ratio	1	0	1.41
PL	mRNA stability	1	0	1.36
pVTA	alternative polyA	0	0	1.44
pVTA	alternative TSS	0	0	1.39
pVTA	gene expression	0	0	1.42
pVTA	isoform ratio	0	0	1.35
pVTA	intron excision ratio	0	0	1.39
pVTA	mRNA stability	0	0	1.46
RMTg	alternative polyA	0	0	1.56
RMTg	alternative TSS	0	0	1.34
RMTg	gene expression	0	0	1.41
RMTg	isoform ratio	0	0	1.49
RMTg	intron excision ratio	0	0	1.32
RMTg	mRNA stability	0	0	1.45